Lin Y - Search Results

1

HDAC10 switches NLRP3 modification from acetylation to ubiquitination and attenuates acute inflammatory diseases.

Yang M, Qin Z, Lin Y, Ma D, Sun C, Xuan H, Cui X, Ma W, Zhu X, Han L. Yang M, et al. Among authors: lin y. Cell Commun Signal. 2024 Dec 20;22(1):615. doi: 10.1186/s12964-024-01992-1. Cell Commun Signal. 2024. PMID: 39707387 Free PMC article.

2

TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.

Lin Y, Lv X, Sun C, Sun Y, Yang M, Ma D, Jing W, Zhao Y, Cheng Y, Xuan H, Han L. Lin Y, et al. EMBO Rep. 2022 Nov 7;23(11):e54569. doi: 10.15252/embr.202154569. Epub 2022 Sep 30. EMBO Rep. 2022. PMID: 36178239 Free PMC article.

3

TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.

Ma X, Ma X, Qiu Y, Zhu L, Lin Y, You Y, Ma D, Qin Z, Sun C, Zhao Y, Sun Y, Han L. Ma X, et al. Among authors: lin y. Cell Death Dis. 2018 May 22;9(6):608. doi: 10.1038/s41419-018-0644-4. Cell Death Dis. 2018. PMID: 29789583 Free PMC article.

4

TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression.

Qiu Y, Liu P, Ma X, Ma X, Zhu L, Lin Y, You Y, Yu W, Ma D, Sun C, Qin Z, Zhao Y, Shi J, Han L. Qiu Y, et al. Among authors: lin y. Biochim Biophys Acta Mol Cell Res. 2019 Sep;1866(9):1412-1420. doi: 10.1016/j.bbamcr.2019.06.002. Epub 2019 Jun 6. Biochim Biophys Acta Mol Cell Res. 2019. PMID: 31176697 Free article.

5

The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein.

Zhu L, Qin C, Li T, Ma X, Qiu Y, Lin Y, Ma D, Qin Z, Sun C, Shen X, Zhao Y, Han L. Zhu L, et al. Among authors: lin y. Cell Death Differ. 2020 Jun;27(6):1819-1831. doi: 10.1038/s41418-019-0464-9. Epub 2019 Dec 4. Cell Death Differ. 2020. PMID: 31802035 Free PMC article.

6

NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma.

Ma X, Qiu Y, Zhu L, Zhao Y, Lin Y, Ma D, Qin Z, Sun C, Shen X, Li T, Han L. Ma X, et al. Among authors: lin y. J Mol Med (Berl). 2020 Feb;98(2):221-232. doi: 10.1007/s00109-019-01868-9. Epub 2019 Dec 23. J Mol Med (Berl). 2020. PMID: 31872284

7

NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway.

Ma X, Qiu Y, Sun Y, Zhu L, Zhao Y, Li T, Lin Y, Ma D, Qin Z, Sun C, Han L. Ma X, et al. Among authors: lin y. Cell Death Dis. 2020 Mar 6;11(3):174. doi: 10.1038/s41419-020-2368-5. Cell Death Dis. 2020. PMID: 32144252 Free PMC article.

8

Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.

Ma D, Yang M, Wang Q, Sun C, Shi H, Jing W, Bi Y, Shen X, Ma X, Qin Z, Lin Y, Zhu L, Zhao Y, Cheng Y, Han L. Ma D, et al. Among authors: lin y. Sci Adv. 2021 Mar 24;7(13):eabc1834. doi: 10.1126/sciadv.abc1834. Print 2021 Mar. Sci Adv. 2021. PMID: 33762328 Free PMC article.

9

Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.

Sun C, Xue M, Yang M, Zhu L, Zhao Y, Lv X, Lin Y, Ma D, Shen X, Cheng Y, Xuan H, Jia X, Li T, Han L. Sun C, et al. Among authors: lin y. mSphere. 2021 Oct 27;6(5):e0075221. doi: 10.1128/mSphere.00752-21. Epub 2021 Oct 13. mSphere. 2021. PMID: 34643417 Free PMC article.

10

Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC.

Sun C, Jing W, Xiong G, Ma D, Lin Y, Lv X, Zhao Y, Ma X, Zhu L, Shen X, Yang M, Qin Z, Cheng Y, Xuan H, Li T, Han L. Sun C, et al. Among authors: lin y. Cancer Lett. 2022 Feb 1;526:180-192. doi: 10.1016/j.canlet.2021.11.005. Epub 2021 Nov 8. Cancer Lett. 2022. PMID: 34762994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,503 results

Search Page

Filters